All lobbying filings

Ballard Partners

Ballard Partners filed a Q2 report for Rio Biopharmaceuticals, Inc. on July 16, 2026, reporting $150,000 in lobbying income.

Lobbying for Rio Biopharmaceuticals, Inc. · Pharmaceutical company

As filed: BALLARD PARTNERS for RIO BIOPHARMACEUTICALS, INC.

All filings by Ballard Partners · Everything Rio Biopharmaceuticals, Inc. has reported

Filing · LD-2 quarterly report Q2 report

Reporting period

2nd Quarter 2026

Apr 1 - June 30 · Posted Jul 16, 2026

Income

$150,000

What the client paid this registrant for the period.

Client based in

New Jersey

Official filing document

Government bodies contacted 1

Health & Human Services, Dept of (HHS)

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 1

Pharmacy

Assisting with applications before the Food & Drug Administration for generic pharmaceutical approvals.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.